LONG-TERM COST-EFFECTIVENESS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THAILAND

被引：0
|
作者：
Permsuwan, U. [1 ]
Yamwong, S. [2 ]
Tinmanee, S. [3 ]
Sritara, P. [2 ]
机构：
[1] Chiang Mai Univ, Chiang Mai 50000, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Bangkok 10700, Thailand
[3] AstraZeneca Thailand Ltd, Bangkok, Thailand
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.196
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A633 / A633
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN SWEDEN
    Thurston, S.
    Webb, C.
    Borgman, B.
    Van Hout, B.
    VALUE IN HEALTH, 2010, 13 (03) : A166 - A167
  • [32] Long-term cost-effectiveness of clopidogrel in STEMI patients
    Zhang, Zefeng
    Kolm, Paul
    Mosse, Frederique
    Jackson, Joseph
    Zhao, Liping
    Weintraub, William S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (03) : 353 - 360
  • [33] Erratum to: Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Ulrike Theidel
    Christian Asseburg
    Evangelos Giannitsis
    Hugo Katus
    Clinical Research in Cardiology, 2013, 102 (6) : 477 - 477
  • [34] COST EFFECTIVENESS OF THE USE OF TICAGRELOR VERSUS COPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME IN COLOMBIA
    Romero Prada, M. E.
    Roa Cardenas, N. C.
    Huerfano, L. M.
    VALUE IN HEALTH, 2017, 20 (09) : A916 - A916
  • [35] COST-EFFECTIVENESS OF TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME: RESULTS FROM THE PLATO STUDY: A CANADIAN ANALYSIS
    Mittmann, N.
    Chan, B.
    Seung, S. J.
    Liovas, A.
    Cohen, E.
    VALUE IN HEALTH, 2011, 14 (07) : A378 - A379
  • [36] Long-term cost-effectiveness of clopidogrel in patients having percutaneous coronary intervention early after acute coronary syndrome: Results from PCI-CURE
    Weintraub, WS
    Mahoney, EM
    Mehta, S
    Lamy, A
    Yuan, Y
    Chen, R
    Jackson, J
    Gabriel, S
    Bouin, O
    Spiesser, J
    Yusuf, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 296A - 296A
  • [37] COST-EFFECTIVENESS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH RIVAROXBAN IN AUSTRALIA
    Gao, L.
    Li, S. C.
    VALUE IN HEALTH, 2014, 17 (07) : A760 - A760
  • [38] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME (ACS) PATIENTS IN SPAIN
    Thurston, S.
    Webb, C.
    Rejas, J.
    Van Hout, B.
    VALUE IN HEALTH, 2010, 13 (03) : A165 - A166
  • [39] Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial
    Agus, A.
    Hulme, C.
    Verghis, R. M.
    McDowell, C.
    Jackson, C.
    O'Kane, C. M.
    Laffey, J. G.
    McAuley, D. F.
    CRITICAL CARE, 2017, 21
  • [40] COST-EFFECTIVENESS ANALYSIS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR VERSUS CLOPIDOGREL IN HONG KONG: A MARKOV ANALYTIC MODEL
    Lee, V. W. Y.
    Chow, I. H. I.
    Yan, B. P.
    Yu, C. M.
    Lam, Y. Y.
    VALUE IN HEALTH, 2012, 15 (07) : A371 - A371
12345